Blog - Page 4986 of 5568

MondayNov 05, 2007 4:36 am

Fortified Holdings Corp. (FFDH.OB) teams with Microsoft and 3Sharp

Fortified Holdings Corp. (FFDH.OB) announced that the company has teamed with Microsoft Corporation and 3Sharp of Redmond, WA to develop an exclusive application that utilizes Fortified DataCom's NOMAD Incident Command Platform. This platform will allow first responders and humanitarian workers to streamline the emergency shelter registration processes. The project, spearheaded by Microsoft, is focused on assisting humanitarian agencies in their ability to register and process displaced persons at emergency shelter locations during times of crisis. The program will automate registration forms and easily upload information so that all materials are readily available to deploy. This solution will rely on the…

SundayNov 04, 2007 7:29 pm

Wall St. Closes Green as Tech Sector Overshadows Credit Fears

Stocks closed green on Friday after a late day rally occurred in both industrial, technology and energy sectors on Wall Street. Stocks spent most of the day in the red, threatening to compound with Thursday's sell off as mounting fears that the worst effects of the credit crunch have not been realized Regardless, momentum in big-cap technology stocks such as Google and big-cap energy stocks such as Schlumberger were aided by a 2% rise in oil price, which helped both stocks in the last hour of trading. Coincidentally, stocks such as Caterpillar and Honeywell also closed green after a strong US..…

SundayNov 04, 2007 7:27 pm

Weekly Market Review for the Last Week of October

Volatility in Wall Street was the name of the game this week. U.S. Stocks went up on Monday, down on Tuesday, up on Wednesday, way down on Thursday, before closing green on Friday. Some investors have stated that the slowing housing market, huge subprime related corporate write downs, weak manufacturing growth, oil at $94 a barrel and gold at $800 an ounce will lead to a significant recession looming. Others have stated that the Federal Reserve rate cuts, robust jobs growth, and an advance in our country's Gross Domestic Product will lead to a resilient and continually growing economy. It…

SundayNov 04, 2007 5:25 am

November 5th CEOcast Weekly Newsletter

11/04/2007 VOLUME 324 Companies featured in this edition of the newsletter: ACCP, ACTC, AVGO, CBMC, CGXP, CHIP, CLXS, CVM, DOC, ENZ, GNBT, HYTM, ISON, ITUI, MBND, MSHI, PBIO, PLKH, RVEP, SCLL, SMGY, XCPL There was certainly no shortage of news for the financial community to digest last week, and the market’s volatility was an apparent indicator. The Dow lost 211 points for the week, lowering its annual gain to 9.0%. The Nasdaq bucked the trend, adding 6 points for the week, and raising its annual return to 16.3%. The S&P lost 25 points, trimming its yearly advance to 6.4%. The…

SaturdayNov 03, 2007 5:33 am

StockGuru Blog: China Media Group (CHMD) Continues to Broaden Its Media Interests in China

StockGuru Profile NEWS BLOGS What you need to know! Investing in CHINA Makes Good Sense! CHMD is becoming a true media group with a broad range of interests in China. This company continues to add dimension to their media interests in China which are incredibly broad ranging. While the individual accomplishments are impressive it is important to stand back and take an overall look at this company. Each incremental success adds to the over-arching success of the company. It is completely reasonable to assume that the individual elements of this company will not only strengthen the company but are the…

FridayNov 02, 2007 6:08 pm

IDM Pharma, Inc. (IDMI) Updates Shareholders on Cancer Clinical Trial

IDM Pharma, Inc. (IDMI) updated shareholders on results from the Phase 2 UVIDEM® (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). These updated clinical trial results have shown that the investigational agent "UVIDEM" induction into human immune systems was well tolerated with patients suffering advanced melanoma. The data was presented during a poster session at the International Society for Biological Therapy of Cancer (iSBTc) annual meeting today in Boston. "There is a distinct need in the medical community for new treatments for metastatic melanoma," said Dr. Antoni Ribas, associate professor of medicine and surgery at UCLA and associate director of tumor immunology at…

FridayNov 02, 2007 6:06 pm

Fox Petroleum (FXPE.OB) Enters into an Agreement to Acquire Additional Property

Fox Petroleum Inc. (FXPE.OB) announced that it has signed an agreement to acquire approximately 5,000 acres of additional land in the company's already pertinent North Slope Property. This will increase land acreage from 32,000 acres to 37,000 acres, which is a significant development for the company. According to the terms of this agreement, Fox will acquire a 100% working interest on these new leases leases; on which there is a 5% ORRI to the original assignees, Mr Daniel Donkel and Mr Samuel Cade, and a state royalty of 16.67%. "We're delighted to announce that we have signed the agreement to…

FridayNov 02, 2007 6:04 pm

NexMed, Inc. (NEXM) Appoints Hem Pandya as Chief Operating Officer

NexMed, Inc. (NEXM), a developer of innovative products based on the company's proprietary NexACT drug delivery technology, announced that Hem Pandya has been elected as the company's Chief Operating Officer. Mr. Pandya will fill the company's newly created position and report directly to Chief Executive Officer, Vivian Liu. Mr. Pandya recently served as Chief Commercial Officer for Putney, Inc., a start-up veterinary pharmaceutical company. Previous to this position, Mr. Pandya served as Senior Vice President of Business Development and Strategic Alliances for Andrx Pharmaceuticals, Inc., where he was in charge of licensing and co-development opportunities with various partners. Ms. Liu, CEO…

FridayNov 02, 2007 6:02 pm

Cyplasin Biomedical Ltd (CYPL.OB) Granted New U.S. Patent

Cyplasin Biomedical Ltd (CYPL.OB) announced that the company has been awarded a new U.S. Patent application entitled "Cytotoxic Cyplasin of the Sea Hare, Aplysia punctata, cDNA Cloning and Expression of Bioreactive Recombinants" earlier today. This patent, US 7,271,242 B2, was granted to cover the production of a cytotoxic protein by mammalian cells and the use these cells to treat cancer. Professor Christian Petzelt, Chief Scientific Officer of Cyplasin Biomedical Ltd., commented, "This patent is an important milestone to define our intellectual property for the production method of the cytotoxic cyplasin and related proteins and its application as a substance to…

FridayNov 02, 2007 12:20 pm

ECOtality, Inc. (ETLY.OB) Appoints Slade Mead to Board of Directors

ECOtality announced today that it has appointed Mr. Slade Mead to the Board of Directors. He is a lawyer, professional sports consultant and former Arizona State Senator. Mr. Mead has won multiple awards, including Arizona School Board Legislator of the Year, Arizona Women’s Political Caucus Legislator of the Year, and Arizona Career Technical Education Policy Maker of the Year. Jonathan Read, President & CEO of ECOtality, stated, “We are pleased to welcome Mr. Mead to the ECOtality Board of Directors. Mr. Mead possesses a broad legal and political background with tremendous expertise in government relations that will further strengthen the…

Site Search

Company Search